Status: current, Defined. Date: 30-Sep 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2077561000168113 | Oxaliplatin (Apo) (oxaliplatin 100 mg / 20 mL) concentrated injection, 1 x 20 mL vial (containered trade product pack) | en | Fully specified name | Inactive | Case sensitive | Australian Medicines Terminology module |
| 2077571000168119 | Oxaliplatin (Apo) 100 mg/20 mL concentrated injection, 20 mL vial | en | Synonym | Inactive | Case sensitive | Australian Medicines Terminology module |
| 2976091000168117 | Oxaliplatin (Apo) (oxaliplatin 100 mg / 20 mL) injection, 1 x 20 mL vial (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2976101000168110 | Oxaliplatin (Apo) 100 mg/20 mL injection, 20 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Oxaliplatin (Apo) 100 mg/20 mL injection, 20 mL vial | Is a | Oxaliplatin (Apo) 100 mg/20 mL injection, 20 mL vial | true | Inferred relationship | Some | ||
| Oxaliplatin (Apo) 100 mg/20 mL injection, 20 mL vial | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Oxaliplatin (Apo) 100 mg/20 mL injection, 20 mL vial | has TPUU | Oxaliplatin (Apo) 100 mg/20 mL injection, 20 mL vial | true | Inferred relationship | Some | 1 | |
| Oxaliplatin (Apo) 100 mg/20 mL injection, 20 mL vial | has container type | vial | true | Inferred relationship | Some | ||
| Oxaliplatin (Apo) 100 mg/20 mL injection, 20 mL vial | has TP | Oxaliplatin (Apo) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR